
Laboratory Corporation of America Holdings LH
$ 254.3
-1.99%
Annual report 2025
added 02-24-2026
Laboratory Corporation of America Holdings Depreciation & Amortization 2011-2026 | LH
Annual Depreciation & Amortization Laboratory Corporation of America Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 681 M | 644 M | 577 M | 537 M | 577 M | 625 M | 577 M | 552 M | 533 M | 499 M | 458 M | 246 M | 230 M | 230 M | 231 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 681 M | 230 M | 480 M |
Quarterly Depreciation & Amortization Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.5 M | 68.3 M | 167 M | - | 63.7 M | 62.2 M | 154 M | - | 55.7 M | 51.5 M | 142 M | - | 49 M | 49.8 M | 162 M | - | 557 M | 92.4 M | 184 M | - | 441 M | 288 M | 145 M | - | 421 M | 277 M | 136 M | - | 414 M | 281 M | 143 M | - | 388 M | 255 M | 128 M | - | 369 M | 248 M | 122 M | - | 340 M | 220 M | 103 M | - | 182 M | 124 M | 246 M | - | 170 M | 112 M | 55.5 M | - | 170 M | 113 M | 56.7 M | - | 174 M | 116 M | 58.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 557 M | 49 M | 183 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
321 M | $ 110.6 | -3.73 % | $ 33.6 B | ||
|
Castle Biosciences
CSTL
|
16 M | $ 23.44 | -5.12 % | $ 651 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 18.99 | -13.35 % | $ 1.01 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 14.66 | -4.18 % | $ 443 M | ||
|
Illumina
ILMN
|
354 M | $ 120.13 | -5.35 % | $ 19.1 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.1 | -2.57 % | $ 1.97 B | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 162.62 | -2.45 % | $ 8.06 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
39.7 M | $ 79.72 | -4.09 % | $ 9.99 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 80.4 | -3.77 % | $ 5.43 B | ||
|
Personalis
PSNL
|
10.9 M | $ 4.97 | -9.64 % | $ 294 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.48 | -9.72 % | $ 270 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 410.54 | 0.19 % | $ 11.8 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 56.25 | -4.9 % | $ 3.36 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 117.34 | 14.49 % | $ 9.68 B | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.4 | -6.87 % | $ 1.08 B | ||
|
Celcuity
CELC
|
167 K | $ 118.34 | -1.44 % | $ 5.53 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 16.06 | -4.66 % | $ 359 M | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.62 | -4.55 % | $ 428 M | ||
|
Natera
NTRA
|
16.7 M | $ 191.44 | -4.36 % | $ 18.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 188.92 | -3.11 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.12 | -3.18 % | $ 174 M | ||
|
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M |